Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REDEEM trial for immune aging and chronic inflammation
NL-OMON61221Phase 2Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2026
- Countries
- 1
01
Overview
Phase 2 trial in chronic inflammation, sponsored by Radboud University Medical Center. Planned start Oct 2026; status: not yet recruiting.
02
Conditions
chronic inflammation
Beyond the preview
Go deeper on NL-OMON61221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61221.